Remedium in the news – How to source and attract overseas doctors by our Director and Co-Founder David Green in Healthcare Global magazine:
Remedium Partners responds to the Home Office’s relaxation of immigration rules for overseas doctors
Following the Home Office’s announcement today that doctors will be excluded from the government’s Tier 2 visa cap, Philip Braham, co-founder of Remedium Partners comments:
“We are delighted that the Government has listened to ongoing concerns about visa caps and has removed its restrictions on the number of overseas doctors that can work in the UK. The NHS has long relied on the knowledge and expertise of this diverse talent pool. However, due to the visa caps a number of our NHS hospital partners have been running rotas with numerous gaps for many months now. Today’s news will allow departments to run safer, more efficient services for patients with larger numbers of staff. We also welcome the news for our community of doctors, many of whom have been waiting for months to relocate. They will now be able to take up their posts and become an integral part of our NHS.
“We are also hopeful that this decision will go a long way towards removing the NHS’s reliance on expensive locum doctors as a short-term solution to staffing gaps. Given that a single locum can cost as much as £100,000 in agency fees alone, the NHS not only stands to save significant amounts of money long term, but it will be better placed to provide patients with continuity of care due to a much larger pool of permanent doctors. And, while today’s decision marks an exciting period of transformation for the NHS, Trusts will need to focus on strategic workforce planning strategies that not only attract overseas doctors to work in their hospitals, but also retain them on a long term basis. Support with relocation, the development of robust induction programmes and access to ongoing professional development will be crucial to the success of Trusts’ long term attraction and retention strategies”.
See our press coverage of this issue here:
Will the government lift the visa cap? Let’s hope so!
Commenting on the speculation that government will lift the visa cap on doctors, Remedium Co-Founder Philip Braham said: ” If this turns out to be true, the news will come as a welcome relief to a number of our NHS hospital partners who have for many months now been running rotas with a number of gaps. It will allow departments to run safer, more efficient services for patients with larger numbers of staff. We also welcome the news for our our community of doctors, many of whom have been waiting for months to relocate. They will now be able to take up their posts and become an integral part of our NHS.”
Long Term, Not Locum – Why Thinking Ahead Is Key For NHS Staffing – Hospital Hub Article by Remedium Directors and Co-Founders Philip Braham and David Green
We were very pleased to see an article appear on the Hospital Hub website in which our Directors and Co-Founders Philip Braham and David Green talk about the importance of strategic, long term workforce planning in the NHS. For More information, click on the link below:
Why diversity of doctors is essential for the NHS – Healthcare Leader article by Remedium Director Philip Braham
We were delighted to see an article appear on the Healthcare Leader website from our Director and Co-Founder Philip Braham on the importance of diversity in the NHS – click on the link below to read the article:
Government must scrap caps on overseas doctors to alleviate skills shortages, says Remedium Partners
Following a recent poll that revealed that the British public support an easing of immigration restrictions for doctors coming to work in the NHS, the government must take urgent action to ensure a healthy supply of overseas talent. That’s according to Remedium Partners.
David Green, co-founder and director of Remedium Partners, said, “This new research supports what we have been saying for some time: highly-skilled doctors sourced from overseas are vital to the NHS and help alleviate the chronic staffing shortages seen in our hospitals. The Royal College of Physicians, The British Medical Association and numerous NHS Trusts have all expressed concerns about staffing levels and the detrimental impact that this has upon patient care. Now, the overwhelming majority of the public are showing their support for these doctors, in recognition of the vital part they play in helping our hospitals deliver the highest standards of care.
“We work closely with NHS Trusts and overseas doctors every day and have seen far too many cases of skilled professionals being offered positions in hospitals, only to be prevented from starting work due to a lack of available visas. The hospitals are then forced to turn to expensive locum doctors to fill the posts, each of which can cost the NHS up to £150,000 a year in agency fees alone. We are two months into the new NHS year and had hoped to see the situation improve. Instead, the problems are continuing.
“We are seeing real strength of feeling from the public and medical professionals. There is overwhelming support for overseas doctors and recognition of their valuable contributions to our healthcare services. We are calling upon the government to relax its current immigration rules so that the NHS is not turning away the doctors that it urgently needs.”
Following BBC reports that immigration rules continue to hamper Trusts’ ability to recruit overseas doctors, prompt government action from the new Home Secretary is vital to avoid further shortages at a time when the UK is facing a dearth of home-grown doctors. That’s according to Remedium Partners.
David Green, co-founder and director of Remedium Partners, said, “As the BBC article reveals, increasing numbers of overseas doctors are being prevented from starting work due to Tier 2 visas caps being reached. Consequently, we would like to see reform of the current visa system to include a much larger number of specialisms under the shortage occupation list.
“Under the current regime, specialities such as Acute and General Medicine – which include Gastroenterology, Geriatric, Respiratory and Stroke – are not defined as shortage occupations. However doctors in these fields are in just as short supply – if not more so- as those that fall under the recognised shortage occupation lists like A&E, Radiology and Paediatrics.
“Prompt government reform will not only help alleviate immediate staffing shortages, but it will also help Trusts with long term workforce planning strategies to ensure they have the talent they need to contend with future pressures such as the annual winter crisis and the UK’s rapidly ageing population.
“As a consultancy which solely focuses on sourcing permanent overseas doctors we are urging the government to do as much as possible to support this highly skilled talent pool access the NHS at a time when the number of UK medical students is rapidly decreasing.”
At a time when the NHS is facing an acute shortage of hospital doctors, there is an increasing reliance on overseas talent to help plug the gap. However, these much-needed medical professionals are facing a number of barriers which prevent them starting work in UK hospitals. That’s according to new research from Remedium Partners, a consultancy which specialises in the recruitment of overseas permanent doctors to ease the NHS’ reliance on locums.
The online poll of overseas medical professionals revealed that the biggest barrier – cited by 51% of respondents – is the International English Language Testing System (IELTS) and the Occupational English Test (OET). Other major barriers include gaining a Certificate of Sponsorship – CoS (12%), salary requirements (10%) and relocation costs (9%).
Commenting on the research Remedium Partners Director and Co-Founder Philip Braham, said:
“While no-one would argue that the ability to communicate in English fluently is obviously important, the central issue is that there is not only a lack of clarity over which test should be taken, but also a major shortage of test centres, which then delays a doctor from being able to start work. While the OET assesses English language ability and communication within a medical context, including patient consultations and the ability to write a referral letter, the IELTS includes a wider academic remit including the ability to write essays as well as an understanding of wider social and cultural values. As a result, while the OET is understandably favoured by doctors as it is deemed more medically relevant, the major shortage of test centres means that some are forced down the IELTS route. This is well-known to be much harder to pass and invariably leads to delays in starting work. The high costs associated with both of these tests can also be prohibitive.
“Our research also demonstrates that even once doctors have passed the requisite English language qualifications, some are still being prevented from actually starting their job because of delays in receiving their Certificate of Sponsorship and other visa hold ups. Remedium Partners has long advocated government reform of the visa system and with numerous overseas doctors being effectively stranded earlier this year because of government imposed caps, it is perhaps more important than ever that steps are taken to remedy this to ensure a steady flow of overseas talent.”
Fellow Remedium Co-Founder and Director, David Green, added: “If Trusts and patients are to benefit from the skills and experiences that this rich talent pool brings, it is vital that more is done to make their transition as straightforward as possible. And while Remedium Partners works very closely with our network of medical professionals to guide them through not only the English language tests, but also pre-employment paperwork, we strongly believe that government and regulators must take steps to reform the current systems which are struggling to cope with the demands placed on them.”
Remedium Partners responds to the GMC’s move to support the flow of overseas doctors
Following the General Medical Council’s announcement that it is adding additional test dates for the Professional and Linguistic Assessments Boards (PLAB) exams, in a move aimed at supporting a healthy supply of doctors to the UK, David Green, Co-Founder of special medical recruitment consultancy, Remedium Partners comments:
“As a specialist consultancy that focuses on bringing in talented doctors from overseas to fill permanent posts within NHS Trusts, we welcome the news that the GMC is taking active steps to increase the flow of overseas doctors by adding additional dates at weekends for individuals seeking to take the PLAB exams. It’s no secret that hospitals are facing acute skills shortages and, as a result, are increasingly relying on the expertise of overseas doctors. And with the GMC predicting that over 5,000 doctors will sit the PLAB exams this year alone, up from 3,000 in 2017, it is encouraging to see that active steps to break down the barriers that prevent them from working in the UK are being taken.
“While we wholeheartedly support this move, it can’t be forgotten that there are other bureaucratic barriers that overseas doctors face – namely securing visas – that either delay or, in some cases, stop them practicing in the UK that also need consideration. Consequently we would like to see the Government address this, for example by relaxing and reforming the current visa system to ensure that it is as easy as possible for talented health professionals to access the system.”
Leading permanent medical recruitment specialist Remedium Partners are delighted to welcome senior business leaders Tony Bourne and Robert Dreyfuss to their board as Non-Executive Directors.
Tony and Robert combine to bring the best of healthcare, international trade and brand building experience respectively having held high profile posts in organisations including the British Medical Association, Spire Healthcare and Rotary Watches, driving growth and success internationally.
Speaking about the appointments, Directors and Co-Founders Philip Braham and David Green said: “We are delighted to welcome Tony and Robert to the Remedium Partners board. They bring a unique combination of extensive international business experience and governance, combined with an in-depth knowledge of the healthcare industry, which is already adding significant value to our business.”
Upon joining, Tony commented: “The first moment I saw what the Remedium team were doing, I was very impressed and keen to be involved. Having worked in the healthcare industry extensively, I can see the fantastic growth potential in this business. It has a dynamic offering and skill set, from which both the NHS and overseas doctors immensely benefit. I look forward to providing insight and adding further value, as Remedium continues to influence the NHS positively and grow, both in the UK and overseas in 2018.”
Robert also added: “I am delighted to be part of the Remedium team at this exciting time of growth. I have been impressed by the visionary approach of the founders, Philip and David, and the proactive, positive ethos of the team as a whole. This unique organisation has a strong focus on helping the NHS eliminate locum spend and I am pleased to be able to provide strategic support and advice from my extensive business experience.”
In addition to his role at Remedium Partners, Tony Bourne holds senior positions at several healthcare related businesses including Spire Healthcare Group, Barchester Healthcare and Totally Plc. He has also held senior positions at Bioquell Plc, the World Medical Association and the British Medical Association, as well as several charity, housing and private sector organisations. Robert Dreyfuss is a former Chairman and CEO of Rotary Watches, where he worked for over 30 years and was awarded the Queens Award for Export in 2014.
Leading permanent medical recruitment specialist Remedium Partners were recognised as a “Highly Commended” Recruitment Services Provider, at the inaugural HSJ Partnership Awards 2018.
Held on the 8th March at the prestigious Banking Hall in the City of London, the Awards recognise the best suppliers to the NHS and were judged by a panel of over 50 senior health leaders.
Commenting after having attended the event, Remedium’s Co-Founder and Director Philip Braham said: “We are delighted to have received this fantastic piece of recognition by the industry. From a long list of 15, to a finalist shortlist of five, we are pleased that the judges recognised our unique, strategic workforce transformation offering to the NHS and the passion with which we provide it, with this commendation.”
In January, the senior team presented to a panel of experts, highlighting the unique way in which the company has worked with over 60 Trusts, placing over 500 doctors and saving the NHS in excess of £50M. The presentation also covered how the firm has a deep understanding of the current needs and priorities of the NHS, the importance of collaborative working and how Remedium’s specialist Care and Transition Team is a huge differentiator when it comes to candidate care for their doctors.
Fellow Co-Founder and Director David Green added: “All of us here at Remedium are incredibly excited about this news. Both the teams in the UK and India work so hard to ensure our doctor-candidates and Trust-clients receive the best possible service, whilst ensuring that we are creating cost efficiencies and improvements in the NHS with every placement. We now look forward to working with even more doctors and Trusts as a Highly Commended supplier in 2018!”
The awards were attended by over 450 guests who came to celebrate accolades covering technology, facilities and estates, consulting, pharmaceutical, data and legal services, as well as workforce solutions.
On the 8th February 2018, the General Medical Council (GMC) which regulates doctors in the UK, announced it will routinely accept OET – the Occupational English Test – as an alternative proof of English proficiency for registration purposes. This means doctors no longer have to pass IELTS and can take the more medically relevant OET. To find out more, access our OET Factsheet
Remedium Partners welcome healthcare recruitment expert Andy Tibbs to their team as they continue to grow into 2018.
After a record breaking 2017, leading permanent medical recruitment specialist Remedium Partners are delighted to announce the appointment of senior healthcare recruitment expert Andy Tibbs to their team for 2018.
With over 15 years’ experience in placing medical specialists across the UK and having worked with over 200 NHS Trusts, Andy has joined the company as Commercial Director. Working across the public sector and NHS, Andy has an extensive track record in building exceptional resourcing relationships with Trusts and brings with him a track record of delivering real results and value for money to hospitals and health leaders.
Speaking about the appointment, Directors and Co-Founders Philip Braham and David Green said: “We are delighted to welcome Andy to the Remedium Partners family. His industry knowledge, extensive contacts and commercial acumen will ensure that we continue to build on our relationships with Trusts throughout the UK and Ireland, placing even more permanent doctors and ultimately saving the Health Service even more money than we did in 2017.”
Upon joining, Andy said: “I am delighted and honoured to have been appointed as Commercial Director. Remedium Partners are a vibrant, innovative and professional business, led by an inspirational management team that sources the best doctors from around the world into permanent roles in the NHS. The business is a true partner to any of the Trusts it supports and is perfectly aligned to the latest NHS strategies in driving down locum usage, cost reduction and strengthening trusts substantive workforce. I am incredibly excited to be involved with such a successful and passionate brand like Remedium Partners and look forward to seeing the positive impact we will have for many Trusts in 2018.”
Andy comes to the business having held senior positions in recruitment and healthcare companies, including A&E Agency, Interact Medical and Independent Clinical Services.
We are delighted to be announced as a finalist for the HSJ Healthcare Partnership Awards 2018 as Recruitment Services Provider! Congrats to all other finalists – see you on the 8th March!
More information: https://partnership.hsj.co.uk/2018-shortlist
At Remedium Partners we believe strongly in holding and attending events. We like to reach out to both our Candidates and our Clients.
In an industry teeming with activity, we have a team of highly qualified consultants who carefully select the events that we attend we attend.
In 2018 we will be attending many industry relevant events where we hope to see our clients and in turn we will be hosting several recruitment drives across Europe and the South Continent to meet with our future Candidates.
We are always on the lookout for new events to be a part of and if you have any events in particular that you think we should attend then please feel free to let us know.